Charles Albright
2016
In 2016, Charles Albright earned a total compensation of $2.7M as Chief Scientific Officer at Editas Medicine.
Compensation breakdown
| Non-Equity Incentive Plan | $44,297 |
|---|---|
| Option Awards | $2,506,028 |
| Salary | $136,538 |
| Total | $2,686,863 |
Albright received $2.5M in option awards, accounting for 93% of the total pay in 2016.
Albright also received $44.3K in non-equity incentive plan and $136.5K in salary.
Rankings
In 2016, Charles Albright's compensation ranked 3,632nd out of 14,075 executives tracked by ExecPay. In other words, Albright earned more than 74.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,632 out of 14,075 | 74th |
Division Manufacturing | 1,270 out of 5,489 | 77th |
Major group Chemicals And Allied Products | 393 out of 1,895 | 79th |
Industry group Drugs | 287 out of 1,538 | 81st |
Industry Biological Products, Except Diagnostic Substances | 56 out of 279 | 80th |
Source: SEC filing on April 26, 2017.
Albright's colleagues
We found two more compensation records of executives who worked with Charles Albright at Editas Medicine in 2016.